Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
cancer
3
×
clinical trials
life sciences
national blog main
blueprint medicines
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
andrew berens
arena pharmaceuticals
avapritinib
biotech
boston
cardiovascular disease
colorectal cancer
companion diagnostic
deciphera pharmaceuticals
dna sequencing
What
cancer
drug
fda
3
×
medicine
3
×
announced
approval
approved
blueprint
chasing
deadly
deciphera
deeper
dna
eisai
filing
fingerprint
flags
forms
genetic
gi
going
higher
incidence
lorcaserin
loss
market
marketing
matter
morning
nd
new
oks
patients
pharamceuticals
plans
post
pulls
risks
second
seek
Language
unset
Current search:
medicine
×
cancer
×
fda
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues